In A549 cells in which PAR1 was knocked down, the tumor formation rate and degree of malignancy were reduced compared with those of wild-type cells, and PAR1-deficient cells showed a loss of sensitivity to doxycycline (Figure 6H). The gene discussed is F2R; the disease is neoplasm.